Company Overview
About twoplus fertility
Twoplus Fertility is a Singapore-based consumer fertility health company — backed by Y Combinator (S20) with $5.3 million raised including a $5.15 million seed round led by Monk's Hill Ventures in May 2022 — providing couples experiencing difficulty conceiving with at-home fertility products designed as non-invasive, affordable alternatives to clinical fertility treatments, starting with the Twoplus Sperm Guide applicator (an at-home cervical cap applicator that positions sperm closer to the cervix during natural conception attempts, increasing the probability of fertilization for couples with mild male factor infertility or unexplained subfertility). Founded in 2019 by Prusothman Raja and Benjamin Tee, Twoplus became revenue-generating in 2024 and distributes products in Singapore, the United Kingdom, and the United States.
Business Model & Competitive Advantage
Twoplus Fertility's product design addresses the accessibility and cost gap between over-the-counter fertility aids (ovulation tests, prenatal vitamins) and clinical fertility treatments (IUI starting at $1,000-3,000 per cycle, IVF starting at $10,000-20,000 per cycle): couples who have been trying to conceive for 6-12 months typically exhaust inexpensive interventions (timing intercourse, lifestyle changes) before the prohibitive cost of clinical fertility procedures drives them to 'try harder' with existing approaches rather than seek medical help. The Twoplus Applicator serves the intervention gap — a clinically informed, at-home device that improves natural conception odds for couples with mild male factor fertility challenges (low sperm count, reduced motility) or cervical mucus barriers by delivering sperm directly past the vaginal canal to the cervical os, replicating the first step of intrauterine insemination (IUI) without the clinic visit. The product launches in Singapore, UK, and US markets where fertility health consumer awareness is high and the customer acquisition cost for the fertility-aware demographic is manageable through digital health channels.
Competitive Landscape 2025–2026
In 2025, Twoplus Fertility competes in the consumer fertility, femtech, and at-home fertility treatment market with Mosie Baby (home insemination kit, acquired by Preseed), Natalist (fertility supplement and testing brand, acquired by Hers), and Legacy (male fertility testing, $25M raised) for consumer fertility product spending and digital health adoption. The global fertility treatment market ($24B+ in 2024, projected $38B by 2030) has significant consumer retail opportunity in the pre-clinical intervention tier — couples who will eventually pursue IVF but are looking for lower-cost interventions first represent a large addressable market that clinical fertility practices don't serve economically. Y Combinator S20 backing positioned Twoplus at the intersection of femtech and consumer health. Monk's Hill Ventures' Southeast Asia focus reflects the Singapore fertility health market opportunity and the APAC digital health distribution potential. The 2025 strategy focuses on growing the UK and US direct-to-consumer e-commerce channel, building the subscription model (monthly fertility wellness bundles combining the Applicator with supplements and cycle tracking), and pursuing regulatory clearances for the international market expansion.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
twoplus fertility is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Compare twoplus fertility with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from twoplus fertility? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim twoplus fertility Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention twoplus fertility vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →